首页> 中文期刊> 《医学综述》 >半胱氨酰白三烯及其受体拮抗剂在癌症中作用的研究进展

半胱氨酰白三烯及其受体拮抗剂在癌症中作用的研究进展

         

摘要

Cancer is one of the diseases threatening the health of residents in China ,whereas its mechanisms are com-plicated.Inflammation and its mediators play an improtant and special role in both pathogenesis and development of cancer. Cysteinyl leukotrienes are generated in enzyme pathway of arachidonic acid lipid oxidatio ,which participate in the cascade of inflammation.There is an inextricable relationship between CysLTs and cancer.Nowadays,CysLTs have been improved that can effect the proliferation,apoptosis,invasion and migration of cancer.Therefore,a more further and comprehensive under-standing of CysLTs in cancer can provide a new protential for the treatment of cancer.%癌症的发生、发展机制较为复杂,是目前威胁我国民众健康的疾病之一.炎症及其介质无论是癌症的发病因素还是推进癌症的发展中均发挥着特殊且重要的作用.半胱氨酰白三烯主要由花生四烯酸通过脂质氧化酶途径产生,作为重要的炎性介质之一,参与炎症级联反应,其与癌症的关系密不可分,对癌症的增殖、凋亡、侵袭迁移等有一定作用.因此,深入和全面地了解半胱氨酰白三烯在癌症中的作用将为癌症的治疗提供新思路.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号